AppYea (APYP) Aktie Kurs

AppYea Inc develops wearable monitoring solutions for sleep apnea and snoring treatment, focusing on the DreamIT wristband for snoring biofeedback and the DreamIT PRO wristband for sleep apnea treatment. The SleepX App monitors physiological parameters during sleep using algorithms developed by SleepX, while SleepX PRO is a medical application that identifies sleep apnea episodes without direct user contact. These products target patients seeking non-invasive sleep disorder management through wearable technology. The company's revenue streams come from direct sales of DreamIT, DreamIT PRO, and SleepX PRO to end-users, with the SleepX PRO app specifically positioned as a medical application for sleep apnea monitoring. The DreamIT and DreamIT PRO devices are sold alongside their respective apps, creating a bundled offering for consumers managing sleep-related health issues. The SleepX PRO app's medical certification enables it to be marketed as a healthcare solution rather than a general wellness tool. AppYea Inc's target market includes individuals diagnosed with sleep apnea or chronic snoring, who prefer wearable technology over traditional CPAP machines. The company positions its products as alternatives to conventional treatments, emphasizing convenience and non-invasive monitoring through the SleepX algorithms that process sensor data during sleep. Sales are driven by the medical application status of SleepX PRO, which differentiates it from consumer wellness apps.